Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

NCT03975387 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
106
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor Decision

Conditions

Interventions

Sponsor

Taiho Oncology, Inc.